while many compounds have shown promise in vitro , only zidovudine ( azt ) , a 2',3'-dideoxynucleoside analogue , has demonstrated efficacy in a controlled clinical trial and has been licensed for the treatment of certain subsets of patients with hiv infection .
C0043474
azt
C0019693
hiv infection